Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT01142856 ·Status: COMPLETED ·Phase: PHASE1

Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)

NCT03268603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Repeated Mesenchymal Stem Cell Injections in ALS

NCT04821479 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis

NCT04514952 ·Status: NO_LONGER_AVAILABLE

Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS

NCT06676423 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

NCT01363401 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

NCT03828123 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis

NCT02917681 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)

NCT04488133 ·Status: COMPLETED ·Phase: PHASE4

Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT03537807 ·Status: NO_LONGER_AVAILABLE

A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

NCT01609283 ·Status: COMPLETED ·Phase: PHASE1

Adults With SMA Treated With Nusinersen

NCT04591678 ·Status: COMPLETED

A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)

NCT06910384 ·Status: TERMINATED ·Phase: PHASE2

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS

NCT05003921 ·Status: SUSPENDED ·Phase: PHASE1

Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis

NCT04849065 ·Status: UNKNOWN ·Phase: PHASE2

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

NCT04097158 ·Status: RECRUITING

A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)

NCT04729907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

NCT01348451 ·Status: UNKNOWN ·Phase: PHASE1

Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT02478450 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis

NCT01906658 ·Status: COMPLETED ·Phase: PHASE2

Stem Cell Therapy for Amyotrophic Lateral Sclerosis

NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2

Neurologic Stem Cell Treatment Study

NCT02795052 ·Status: RECRUITING ·Phase: NA

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

NCT01091142 ·Status: COMPLETED ·Phase: PHASE1

CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS

NCT05306457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1